Draft2:NorthStar

Official website

NorthStar was founded to provide environmental abatement services to the northeast United States. By the early 1990’s, it expanded its service offerings to include remediation services and adding deconstruction and facility response capabilities including decontamination & decommissioning, infection control, fireproofing, and emergency and disaster response

It supports the following organizations:

• NNSA production of life-saving medical isotope molybdenum-99

Other part of DOE are also clients of the company

History

NorthStar acquired two specialty companies – Pioneer Maintenance & Erectors, a millwright and rigging company headquartered in Pennsauken, New Jersey and Randolph Construction Services, a specialized design-build contractor headquartered in Pasco, Washington. Pioneer offers its capabilities for installing complex mechanical systems and equipment dismantlement support, respectively, with emphasis in baggage handling systems at the nation’s airports. Randolph is capable of delivering one-of-a-kind industrial, commercial and federal facilities both domestically and abroad. NorthStar provides design-build services primarily to the Federal Government through the Government Services Administration, U.S. Army Corps of Engineers and the Department of Energy with an emphasis in border security facilities.

In early 2014 NorthStar combined with NCM Group to grow revenue and further expand its national footprint to the northwest, southwest and southeast United States. NorthStar acquired WRS Infrastructure and Environment in late 2014 to expand environmental remediation service capabilities.

Components

NorthStar Medical Radioisotopes, LLC

NorthStar Medical Radioisotopes, LLC was founded to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negatively impacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.

NorthStar is expanding rapidly as we progress toward approval and market introduction of our initial product offering. Our first products are Non-HEU 99-Molybdenum and our revolutionary RadioGenix intelligent isotope separation system. NorthStar will be the first domestic producer of 99-Molybdenum in over 25 years and the only supplier of Non-HEU material. Our paradigm shifting RadioGenix technology platform represents a true evolutionary step in isotope availability and ensures a pipeline of future products to diagnose and treat disease.

Clients and projects

• ABB – Combustion Engineering, Windsor, CT
• Accelerated Remediation Company (ARC)
• Bechtel Jacobs Company LLC, Oak Ridge, TN
• BWXT Y-12, LLC, Oak Ridge, TN
• Connecticut Yankee
• Department of Energy (DOE)
• DOE Paducah Gaseous Diffusion Plant, Paducah, KY
• DOE Portsmouth Gaseous Diffusion Plant, Piketon, OH
• Fluor Fernald
• Fluor-B&W Portsmouth, LLC
• General Electric
• Hematite Nuclear Fuel Processing Plant, Festus, MO
• Idaho National Laboratory, Idaho Falls, ID
• Kerr McGee
• LATA Environmental Services of Kentucky, LLC
• Lawrence Livermore National Laboratory
• Magnox Ltd., Chapelcross & Trawsfynydd, UK
• North Wind, Inc.
• Nuclear Fuel Services, Inc.
• Oak Ridge National Laboratory, Oak Ridge, TN
• Phelps Dodge
• Point Beach Nuclear Plant, Point Beach, WI
• University at Buffalo – SUNY, Buffalo, NY
• University of Arizona, Tucson, AZ
• University of Illinois, Urbana, IL
• University of Washington, Seattle, WA
• UT-Batelle, LLC
• Westinghouse Electric Company
• Y-12 National Security Complex, Oak Ridge, TN

Company history with DOE

Medical isotope molybdenum-99

As part of its nuclear nonproliferation mission, and in support of the American Medical Isotopes Production Act of 2012 (AMIPA), the Department of Energy’s National Nuclear Security Administration (DOE/NNSA) is working to develop a reliable and sustainable means of producing the life-saving medical isotope molybdenum-99 (Mo-99) without using highly enriched uranium (HEU). This program is part of DOE/NNSA’s effort to develop and implement technologies to minimize and, to the extent possible, eliminate the civilian use of HEU, including in research reactors and isotope production facilities worldwide.

Since 2009, DOE/NNSA has partnered with U.S. commercial entities to accelerate the development of a diverse set of non-HEU technologies to produce Mo-99 in the United States. DOE/NNSA's current commercial partners include:

• NorthStar Medical Radioisotopes is developing both neutron capture and accelerator-based technologies, which will utilize NorthStar’s RadioGenixTM Tc-99m Generating System.
• SHINE Medical Technologies is developing accelerator technology with LEU fission.
• DOE/NNSA’s cooperative agreements are implemented under a 50%-50% cost-share arrangement, consistent with AMIPA and Section 988 of the Energy Policy Act of 2005. DOE/NNSA’s support to the total project cost of the cooperative agreement partners is up to $25 million each, consistent with policy guidelines from the Organization of Economic Cooperation and Development – Nuclear Energy Agency (OECD-NEA).
• DOE/NNSA makes technical expertise available, on a non-proprietary basis, to existing and potential Mo-99 producers to assist with converting their Mo-99 production processes to use LEU targets, and to develop non-HEU-based Mo-99 production technologies.

Environmental impact

The evaluation of the potential environmental impacts of a proposal to use federal funds to support and accelerate Northstar Medical Radioisotopes' project to develop domestic, commercial production capability for the medical isotope Molybdenum-99 without the use of highly enriched uranium was done by EA.

Contact information

• Individual and contact information
• Location at DOE

External links

• https://nnsa.energy.gov/aboutus/ouroperations/generalcounsel/nepaoverview/nepa/deanorthstar
• https://nnsa.energy.gov/mediaroom/pressreleases/nnsa-awards-over-11-million-accelerate-development-domestic-mo-99-u.s.